A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions like fibromyalgia and nerve pain, researchers found little convincing evidence of real benefit and flagged serious side effects such as delusions and nausea. The lack of data on whether it reduces depression or opioid use adds to the uncertainty.
source https://www.sciencedaily.com/releases/2025/08/250818102944.htm
Sulfolobus islandicus: Expanding the genetic toolkit for drug delivery and
biotechnology applications
-
Sulfolobus islandicus, an archaeal model organism, offers unique advantages
for metabolic engineering and synthetic biology applications owing to its
abili...
7 hours ago
No comments:
Post a Comment